Armistice Capital’s Lexaria Bioscience LEXX Stock Holding History
Bought
Maintained
Sold
Other funds holding LEXX
Armistice Capital's LEXX Position: Q3 2026 in Review
Armistice Capital opened a new position in Lexaria Bioscience (LEXX) in Q3 2026: 172,084 shares worth $542K. The stake represents 0.01% of the portfolio and ranks #200 among its holdings. This is a return to the name: Armistice Capital previously reported a position in LEXX as recently as Q4 2024.
Armistice Capital first reported a position in LEXX in Q3 2023 and has held it in 4 quarters since. The position peaked at $2.84M in Q2 2024. 15 funds tracked by Wall St. Rank hold LEXX as of Q3 2026.
- Armistice Capital held 172,084 shares of Lexaria Bioscience worth $542K as of Q3 2026.
- Lexaria Bioscience was a new Armistice Capital position in Q3 2026.
- Lexaria Bioscience made up 0.01% of Armistice Capital's portfolio in Q3 2026, its #200 holding.
- Armistice Capital first reported a position in Lexaria Bioscience in Q3 2023 and has held it in 4 quarters since.
- Armistice Capital's Lexaria Bioscience position peaked at $2.84M in Q2 2024.
- 15 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q3 2026.
Based on Armistice Capital's 13F filing for Q3 2026, filed 16 Nov 2026.